Breast CancerNCT06185738
WeCanManage. An mHealth Self-management Tool
A study testing WCM app in people with Breast Cancer and Head and Neck Cancer, run by University of Illinois Chicago at 1 site in United States.
Trial summary
Examine the Feasibility, Acceptability, User Satisfaction, and Response Patterns and Preliminary Efficacy on Targeted Patient Reported Outcomes. Using a pre-post, single arm feasibility design with cancer survivors with disabilities Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Breast Cancer, Head and Neck Cancer, Sarcoma
- What is being tested?
- WCM app
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Jul 2024to 1 Aug 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Usability Testing of the WeCanManage High Fidelity Prototype
- Age 18 or older
- Diagnosis of breast cancer, head and neck cancer or sarcoma
- Completion of active treatment
- Self-identify as a person with a disability according to the Americans with Disabilities .Act and the American Community Survey 6-disability questions
- Able to understand and communicate in English
Show all 15Show fewer
- Medically stable enough to participate in two data collection sessions totaling 2 hours
- Evaluation of the WeCanManage App
- Age 18 or older
- Diagnosis of breast cancer, head and neck cancer or sarcoma
- Completion of primary (i.e. surgery, chemotherapy, and/or radiation); may still be under-going endocrine or hormone therapies
- Self-identify as experiencing disabling after-effects of cancer and its treatment according to the Americans with Disabilities Act and the American Community Survey 6-disability questions
- Able to read, understand and communicate in English
- Ownership of a smartphone, tablet, or personal computer.
- Internet access
Who cannot join
- Usability Testing of the WeCanManage High Fidelity Prototype
- No diagnosis of breast cancer, head and neck cancer or sarcoma
- In active treatment
- Does not self-identify as a person with a disability according to the Americans with Disabilities Act and the American Community Survey 6-disability questions
- Not able to understand and communicate in English
- Not medically stable enough to participate in two data collection sessions totaling 2 hours
Show all 14Show fewer
- Evaluation of the WeCanManage App
- Age 17 or younger
- No diagnosis of breast cancer, head and neck cancer or sarcoma
- In active treatment
- Does not self-identify as experiencing long-term effects of cancer and its treatment according to the Americans with Disabilities Act and the American Community Survey 6-disability questions
- Not able to read, understand, and communicate in English
- Does not have access to internet enabled smartphone, tablet, or personal computer
- Does not have access to the internet
Trial locations and contacts
1 site in 1 country.
About this study
Official title: WeCanManage: An mHealth Self-management Tool to Empower Survivors With Disabilities Due to Long-term Effects of Cancer and Its Treatment
Examine the Feasibility, Acceptability, User Satisfaction, and Response Patterns and Preliminary Efficacy on Targeted Patient Reported Outcomes. Using a pre-post, single arm feasibility design with cancer survivors with disabilities
Read the detailed description
Examine the Feasibility, Acceptability, User Satisfaction, and Response Patterns and Preliminary Efficacy on Targeted Patient Reported Outcomes. Using a pre-post, single arm feasibility design with cancer survivors with disabilities, we will collect data on the WeCanManage app delivered self-management intervention's feasibility, acceptability, user satisfaction as well as response patterns and preliminary efficacy on targeted patient reported outcomes.
- Conditions
- Breast Cancer, Head and Neck Cancer, Sarcoma
- Being tested
- WCM app
- Medical subject headings
- Breast Neoplasms, Head and Neck Neoplasms, Sarcoma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
WCM appOther
WCM app evaluation at baseline, at completion of WCM program and 4 weeks after completion of WCM program, by completing PROMIS and Self Efficacy for managing disease scale questionnaires
| Study group | Role | What they receive |
|---|---|---|
| WCM app | Other | WCM app evaluation at baseline, upon completion of WCM program and 4 weeks after completion of WCM program, by completing PROMIS and Self Efficacy for managing disease scale questionnaires Receives: Other: WCM app |
What is being measured
The primary outcome is the main question the study is designed to answer.
Feasibility of WCM app
Evaluate recruitment capability by assessing response rate
Measured: 1 year
Feasibility of WCM app
Number of participants that started the intervention from consent
Measured: 1 year
Acceptability of WCM app
Number of participants that adhered to the intervention
Measured: 1 year
Acceptability of WCM app
Number of participants that were engaged in the intervention
Measured: 1 year
Acceptability of WCM app
Number of participants that were satisfied with the intervention
Measured: 1 year
Acceptability of WCM app
Number of participants that found the intervention helpful
Measured: 1 year
Acceptability of WCM app
Number of participants that wished to continue using the intervention l
Measured: 1 year
Feasibility with WCM app
Measurement of PROMIS questionnaire, low score health good, high score health not good
Measured: Baseline
Feasibility with WCM app
Measurement of PROMIS questionnaire, low score health good, high score health not good
Measured: 4 Weeks
Feasibility with WCM app
Measurement of PROMIS questionnaire, low score health good, high score health not good
Measured: 8 Weeks
Feasibility with WCM app
Measurement of Self Efficacy for managing disease scale questionnaire, low score not confident, high score very confident
Measured: Baseline
Feasibility with WCM app
Measurement of Self Efficacy for managing disease scale questionnaire, low score not confident, high score very confident
Measured: 4 weeks
Feasibility with WCM app
Measurement of Self Efficacy for managing disease scale questionnaire, low score not confident, high score very confident
Measured: 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Dec 2023
- Study start1 Jul 2024
- Primary completion1 Aug 2025
- Study completion1 Aug 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Breast CancerStudies of the same condition, open and under way.
- More trials run by University of Illinois ChicagoThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- All participants will have a data collection session by phone lasting about 60 minutes, and to complete a demographic and health questionnaire, that includes questions such as sex, age, race, ethnicity, marital status, cancer type, time since diagnosis, date of diagnosis, stage of illness, type of primary treatment, type of disability, current activity level, health conditions, annual income, educational history. WeCanManage (WCM) app orientation by Zoom lasting about 60 minutes. Participants will complete WCM app program, about 10 minutes per day for 30 days and up to 45 days. Data collection by phone lasting about 60 minutes after completion of WCM app program and 4 weeks after completion of WCM app program All participants will have an intervention of 4 modules (WeCanRelate, WeCanAdapt, WeCanBe, and WeCanSpeakUp) that are presented as series of micro-learning sessions
- Masking
- None (open label)
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Illinois Chicago
- Sponsor type
- University, hospital or other
- Collaborators
- Northwestern University, Northeastern Illinois University
- Responsible party
- Principal investigator, Susan Magasi, University of Illinois Chicago
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06185738
- Sponsor's protocol ID
- 2020-1067
- Status last verified
- Dec 2025
- First submitted
- 15 Dec 2023
- Last updated
- 15 Dec 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- WeCanManage: An mHealth Self-management Tool to Empower Survivors With Disabilities Due to Long-term Effects of Cancer and Its Treatment
- ClinicalTrials.gov ID
- NCT06185738
- Acronym / sponsor ID
- 2020-1067
- Conditions
- Breast Cancer, Head and Neck Cancer, Sarcoma
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- University of Illinois ChicagoUniversity, hospital or other
- Collaborators
- Northwestern University, Northeastern Illinois University
- Study start
- 1 Jul 2024 (actual)
- Primary completion
- 1 Aug 2025 (actual)
- Study completion
- 1 Aug 2025 (actual)
- First posted
- 29 Dec 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Examine the Feasibility, Acceptability, User Satisfaction, and Response Patterns and Preliminary Efficacy on Targeted Patient Reported Outcomes. Using a pre-post, single arm feasibility design with cancer survivors with disabilities
Detailed description
Examine the Feasibility, Acceptability, User Satisfaction, and Response Patterns and Preliminary Efficacy on Targeted Patient Reported Outcomes. Using a pre-post, single arm feasibility design with cancer survivors with disabilities, we will collect data on the WeCanManage app delivered self-management intervention's feasibility, acceptability, user satisfaction as well as response patterns and preliminary efficacy on targeted patient reported outcomes.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- All participants will have a data collection session by phone lasting about 60 minutes, and to complete a demographic and health questionnaire, that includes questions such as sex, age, race, ethnicity, marital status, cancer type, time since diagnosis, date of diagnosis, stage of illness, type of primary treatment, type of disability, current activity level, health conditions, annual income, educational history. WeCanManage (WCM) app orientation by Zoom lasting about 60 minutes. Participants will complete WCM app program, about 10 minutes per day for 30 days and up to 45 days. Data collection by phone lasting about 60 minutes after completion of WCM app program and 4 weeks after completion of WCM app program All participants will have an intervention of 4 modules (WeCanRelate, WeCanAdapt, WeCanBe, and WeCanSpeakUp) that are presented as series of micro-learning sessions
| Arm | Type | Receives |
|---|---|---|
| WCM app | Other | Other: WCM appWCM app evaluation at baseline, upon completion of WCM program and 4 weeks after completion of WCM program, by completing PROMIS and Self Efficacy for managing disease scale questionnaires |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (15 listed)
- Usability Testing of the WeCanManage High Fidelity Prototype
- Age 18 or older
- Diagnosis of breast cancer, head and neck cancer or sarcoma
- Completion of active treatment
- Self-identify as a person with a disability according to the Americans with Disabilities .Act and the American Community Survey 6-disability questions
Key exclusion criteria (14 listed)
- Usability Testing of the WeCanManage High Fidelity Prototype
- No diagnosis of breast cancer, head and neck cancer or sarcoma
- In active treatment
- Does not self-identify as a person with a disability according to the Americans with Disabilities Act and the American Community Survey 6-disability questions
- Not able to understand and communicate in English
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| WCM appWCM app evaluation at baseline, at completion of WCM program and 4 weeks after completion of WCM program, by completing PROMIS and Self Efficacy for managing disease scale questionnaires | Other | WCM app |
Primary outcome
Feasibility of WCM app
Time frame: 1 year
Evaluate recruitment capability by assessing response rate
Feasibility of WCM app
Time frame: 1 year
Number of participants that started the intervention from consent
Acceptability of WCM app
Time frame: 1 year
Number of participants that adhered to the intervention
Acceptability of WCM app
Time frame: 1 year
Number of participants that were engaged in the intervention
Acceptability of WCM app
Time frame: 1 year
Number of participants that were satisfied with the intervention
Acceptability of WCM app
Time frame: 1 year
Number of participants that found the intervention helpful
Acceptability of WCM app
Time frame: 1 year
Number of participants that wished to continue using the intervention l
Feasibility with WCM app
Time frame: Baseline
Measurement of PROMIS questionnaire, low score health good, high score health not good
Feasibility with WCM app
Time frame: 4 Weeks
Measurement of PROMIS questionnaire, low score health good, high score health not good
Feasibility with WCM app
Time frame: 8 Weeks
Measurement of PROMIS questionnaire, low score health good, high score health not good
Feasibility with WCM app
Time frame: Baseline
Measurement of Self Efficacy for managing disease scale questionnaire, low score not confident, high score very confident
Feasibility with WCM app
Time frame: 4 weeks
Measurement of Self Efficacy for managing disease scale questionnaire, low score not confident, high score very confident
Feasibility with WCM app
Time frame: 8 weeks
Measurement of Self Efficacy for managing disease scale questionnaire, low score not confident, high score very confident
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Dec 2025.
Related trials for Breast Cancer
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 2
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Invasive Mammary Carcinoma, Metastatic Breast Cancer
Not yet recruitingObservational study
Comparison of Reliability, Time Cost, and Participant Comfort of Lymphedema Assessments in Upper Extremity
Lymphedema, Upper Extremity Lymphedema
RecruitingPhase 3
A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
TNBC - Triple-Negative Breast Cancer
RecruitingPhase 3
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing WCM app in people with Breast Cancer and Head and Neck Cancer, run by University of Illinois Chicago at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 15 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Feasibility of WCM app (time frame: 1 year). The study lists 13 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Dec 2025.